Biomimetic Red Blood Cell Membrane-Mediated Nanodrugs Loading Ursolic Acid for Targeting NSCLC Therapy

Biomimetic Red Blood Cell Membrane-Mediated Nanodrugs Loading Ursolic Acid for Targeting NSCLC Therapy

As one of the most common cancers worldwide, non-small-cell lung cancer (NSCLC) treatment always fails owing to the tumor microenvironment and resistance. UA, a traditional Chinese medicine, was reported to have antitumor potential in tumor models in vitro and in vivo, but showed impressive results...

Full description

Bibliographic Details
Main Authors: Ting Wu, Dan Yan, Wenjun Hou, Hui Jiang, Min Wu, Yanling Wang, Gang Chen, Chunming Tang, Yijun Wang, Huae Xu
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Cancers
Subjects:
non-small cell lung cancer
ursolic acid
biomimetic nanocarriers
red blood cell membranes
anticancer therapeutics
apoptosis
Online Access:https://www.mdpi.com/2072-6694/14/18/4520

Similar Items

Similar Items